Chrisopher U Missling

Chrisopher U Missling

Company: Anavex Life Sciences

Job title: President & CEO


Utilizing Precision Genetic Medicine to Treat Rare Neurodevelopmental Diseases: Focusing on Rett Syndrome 9:40 am

Requirement of clear understanding of target engagement Importance of predictive biomarker of response correlating with efficacy Relevance of appropriate efficacy endpointsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.